Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries

English version České info

Background:
Despite large-scale vaccination programmes, pertussis has remained endemic in all European countries and has been on the rise in many countries in the last decade. One of the reasons that have been discussed for the failure of vaccination to eliminate the disease is continued circulation of the pathogen Bordetella pertussis by mostly asymptomatic and mild infections in adolescents and adults. To understand the impact of asymptomatic and undiagnosed infection on the transmission dynamics of pertussis we analysed serological data from five European countries in combination with information about social contact patterns from five of those countries to estimate incidence and reproduction numbers.

Methods and Findings:
We compared two different methods for estimating incidence from individual data on IgG pertussis toxin (PT) titres. One method combines the cross-sectional surveys of titres with longitudinal information about the distribution of amplitude and decay rate of titres in a back-calculation approach. The second method uses age-dependent contact matrices and cross-sectional surveys of IgG PT titres to estimate a next generation matrix for pertussis transmission among age groups. The next generation approach allows for computation of basic reproduction numbers for five European countries. Our main findings are that the seroincidence of infections as estimated with the first method in all countries lies between 1% and 6% per annum with a peak in the adolescent age groups and a second lower peak in young adults. The incidence of infections as estimated by the second method lies slightly lower with ranges between 1% and 4% per annum. There is a remarkably good agreement of the results obtained with the two methods. The basic reproduction numbers are similar across countries at around 5.5.

Conclusions:
Vaccination with currently used vaccines cannot prevent continued circulation and reinfection with pertussis, but has shifted the bulk of infections to adolescents and adults. If a vaccine conferring lifelong protection against clinical and subclinical infection were available pertussis could be eliminated. Currently, continuing circulation of the pathogen at a subclinical level provides a refuge for the pathogen in which it can evolve and adjust to infect vaccinated populations.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries. PLoS Med 7(6): e32767. doi:10.1371/journal.pmed.1000291
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000291

Souhrn

Zdroje

1. RohaniP

EarnDJ

GrenfellBT

2000 Impact of immunisation on pertussis transmission in England and Wales. Lancet 355 285 286

2. GayNJ

MillerE

2000 Pertussis transmission in England and Wales. Lancet 355 1553 1554

3. SchellekensJ

von KonigCH

GardnerP

2005 Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 24 S19 24

4. VersteeghFG

MertensPL

de MelkerHE

RoordJJ

SchellekensJF

2005 Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 133 737 748

5. CorteseMM

BaughmanAL

BrownK

SrivastavaP

2007 A “new age” in pertussis prevention new opportunities through adult vaccination. Am J Prev Med 32 177 185

6. HethcoteHW

1997 An age-structured model for pertussis transmission. Math Biosci 145 89 136

7. Van RieA

HethcoteHW

2004 Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 22 3154 3165

8. van BovenM

de MelkerHE

SchellekensJF

KretzschmarM

2000 Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math Biosci 164 161 182

9. van BovenM

de MelkerHE

SchellekensJF

KretzschmarM

2001 A model based evaluation of the 1996–7 pertussis epidemic in The Netherlands. Epidemiol Infect 127 73 85

10. TozziAE

PandolfiE

CelentanoLP

MassariM

SalmasoS

2007 Comparison of pertussis surveillance systems in Europe. Vaccine 25 291 297

11. CelentanoLP

MassariM

ParamattiD

SalmasoS

TozziAE

2005 Resurgence of pertussis in Europe. Pediatr Infect Dis J 24 761 765

12. de MelkerHE

VersteeghFG

SchellekensJF

TeunisPF

KretzschmarM

2006 The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53 106 113

13. PebodyRG

GayNJ

GiammancoA

BaronS

SchellekensJ

2005 The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 133 159 171

14. SimonsenJ

MolbakK

FalkenhorstG

KrogfeltKA

LinnebergA

2009 Estimation of incidences of infectious diseases based on antibody measurements. Stat Med 28 1882 1895

15. SimonsenJ

StridMA

MolbakK

KrogfeltKA

LinnebergA

2008 Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiol Infect 136 895 902

16. DevilleJG

CherryJD

ChristensonPD

PinedaE

LeachCT

1995 Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 21 639 642

17. HodderSL

CherryJD

MortimerEAJr

FordAB

GornbeinJ

2000 Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis 31 7 14

18. StrebelP

NordinJ

EdwardsK

HuntJ

BesserJ

2001 Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J Infect Dis 183 1353 1359

19. WallingaJ

EdmundsWJ

KretzschmarM

1999 Perspective: human contact patterns and the spread of airborne infectious diseases. Trends Microbiol 7 372 377

20. WallingaJ

TeunisP

KretzschmarM

2006 Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 164 936 944

21. MossongJ

HensN

JitM

BeutelsP

AuranenK

2008 Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5 e74 doi:10.1371/journal.pmed.0050074

22. GiammancoA

ChiariniA

MaplePA

AndrewsN

PebodyR

2003 European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22 112 120

23. VersteeghFG

SchellekensJF

NagelkerkeAF

RoordJJ

2002 Laboratory-confirmed reinfections with Bordetella pertussis. Acta Paediatr 91 95 97

24. TeunisPF

van der HeijdenOG

de MelkerHE

SchellekensJF

VersteeghFG

2002 Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect 129 479 489

25. DiekmannO

HeesterbeekJAP

2000 Mathematical epidemiology of infectious diseases: model building, analysis and interpretation New York Wiley

26. BaughmanAL

BisgardKM

EdwardsKM

GurisD

DeckerMD

2004 Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 11 1045 1053

27. SmieszekT

2009 A mechanistic model of infection: why duration and intensity of contacts should be included in models of disease spread. Theor Biol Med Model 6 25

28. KretzschmarM

MikolajczykRT

2009 Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases. PLoS One 4 e5931 doi:10.1371/journal.pone.0005931

29. AndersonRM

MayRM

1991 Infectious disease of humans: dynamics and control Oxford Oxford University Press

30. WallingaJ

TeunisP

KretzschmarM

2003 Reconstruction of measles dynamics in a vaccinated population. Vaccine 21 2643 2650

31. van BovenM

KretzschmarM

WallingaJ

O'NeillP

WichmannO

2010 Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J Roy Soc Interface In press

32. EdmundsWJ

GayNJ

KretzschmarM

PebodyRG

WachmannH

2000 The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect 125 635 650

33. RichardsonM

EllimanD

MaguireH

SimpsonJ

NicollA

2001 Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 20 380 391

34. MooiFR

van LooIH

KingAJ

2001 Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 7 526 528

35. De GreeffSC

DekkersAL

TeunisP

Rahamat-LangendoenJC

MooiFR

2009 Seasonal patterns in time series of pertussis. Epidemiol Infect 137 1388 1395

36. StorsaeterJ

HallanderHO

GustafssonL

OlinP

2003 Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21 3542 3549

37. CherryJD

GrimprelE

GuisoN

HeiningerU

MertsolaJ

2005 Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 24 S25 S34